• 1. An ionic liquid-based synergistic extraction strategy for rare earths?
  Yingbo Li,Nada Mehio,Huizhou Liu,Sheng Dai Green Chem., 2015,17, 2981-2993
• 2. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 3. An artificial photosynthetic system for photoaccumulation of two electrons on a fused dipyridophenazine (dppz)–pyridoquinolinone ligand?
  Philipp Traber,Stephan Kupfer,Stefanie Gr?fe,Isabelle Baussanne,Martine Demeunynck,Jean-Marie Mouesca,Serge Gambarelli,Vincent Artero,Murielle Chavarot-Kerlidou Chem. Sci., 2018,9, 4152-4159
• 4. An ion-gating multinanochannel system based on a copper-responsive self-cleaving DNAzyme?
  Yang Chen,Di Zhou,Zheyi Meng,Jin Zhai Chem. Commun., 2016,52, 10020-10023
• 5. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554

Introduction to 4-(4-methyl-1,3-thiazol-5-yl)but-3-en-2-one (CAS No. 1021910-48-4)

4-(4-methyl-1,3-thiazol-5-yl)but-3-en-2-one is a significant compound in the field of chemical and pharmaceutical research, characterized by its unique molecular structure and potential biological activities. This compound, identified by the CAS number 1021910-48-4, has garnered attention due to its structural features and its implications in various scientific applications. The presence of a thiazole ring and an α,β-unsaturated ketone moiety makes it a versatile scaffold for further chemical modifications and biological evaluations.

The compound’s molecular formula and structural configuration contribute to its reactivity and potential utility in drug discovery. The thiazole moiety is a well-known pharmacophore found in numerous bioactive molecules, including antibiotics, antifungals, and anti-inflammatory agents. Its incorporation into the molecular framework of 4-(4-methyl-1,3-thiazol-5-yl)but-3-en-2-one suggests that this compound may exhibit similar biological properties or serve as a precursor for the synthesis of more complex derivatives.

In recent years, there has been growing interest in exploring the pharmacological potential of heterocyclic compounds, particularly those containing thiazole derivatives. The α,β-unsaturated ketone group in 4-(4-methyl-1,3-thiazol-5-yl)but-3-en-2-one can participate in various chemical reactions, such as Michael addition and condensation reactions, which are often exploited in medicinal chemistry to develop new therapeutic agents. This structural feature makes it a valuable candidate for further investigation in synthetic chemistry.

Recent studies have highlighted the importance of thiazole-based compounds in addressing various diseases. For instance, derivatives of thiazole have been investigated for their antimicrobial, anti-inflammatory, and anticancer properties. The compound 4-(4-methyl-1,3-thiazol-5-yl)but-3-en-2-one, with its unique structural attributes, may offer new insights into these therapeutic areas. Researchers have been exploring its potential as an intermediate in the synthesis of novel drugs targeting specific biological pathways.

The synthesis of 4-(4-methyl-1,3-thiazol-5-yl)but-3-en-2-one involves multi-step organic reactions that require careful optimization to achieve high yields and purity. The introduction of the thiazole ring into the butenone backbone necessitates precise control over reaction conditions to avoid unwanted side products. Advances in synthetic methodologies have enabled more efficient and scalable production of this compound, facilitating its use in both academic research and industrial applications.

The biological activity of 4-(4-methyl-1,3-thiazol-5-yb-butienenone is another area of active investigation. Preliminary studies suggest that this compound may exhibit inhibitory effects on certain enzymes and receptors involved in disease processes. These findings are particularly intriguing given the broad spectrum of activities observed with other thiazole derivatives. Further research is needed to elucidate the exact mechanisms of action and to identify potential therapeutic applications.

In conclusion, 4-(4-methyl-l.thi-a-zol~5-yI)but~en~one (CAS No. 1021910·48·4) is a promising compound with significant potential in pharmaceutical research. Its unique structural features and reported biological activities make it a valuable scaffold for developing new drugs. As our understanding of heterocyclic chemistry continues to evolve, compounds like this one will play an increasingly important role in addressing unmet medical needs.

• 111600-93-2(5-Ethynyl-4-methylthiazole)
• 18764-34-6(5-Thiazoleacetaldehyde,4-methyl-)
• 165685-93-8(3-(4-methyl-1,3-thiazol-5-yl)propanal)
• 3581-91-7(4,5-Dimethylthiazole)
• 13623-11-5(2,4,5-Trimethylthiazole)
• 1977-06-6((4-Methylthiazol-5-yl)methanol)
• 1759-28-0(4-Methyl-5-vinylthiazole)
• 13669-78-8(Thiazole-4,5-dicarbaldehyde)
• 137-00-8(4-Methyl-5-thiazoleethanol)
• 82294-70-0(4-methyl-1,3-thiazole-5-carbaldehyde)